People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

11.50USD
19 Sep 2014
Price Change (% chg)

$-0.45 (-3.77%)
Prev Close
$11.95
Open
$12.01
Day's High
$12.06
Day's Low
$11.42
Volume
9,558,053
Avg. Vol
5,840,159
52-wk High
$13.80
52-wk Low
$2.26

Search Stocks

Truitt, Joseph 

Brief Biography

Mr. Joseph Truitt is Senior Vice President, Chief Commercial Officer of Achillion Pharmaceuticals Inc. Prior to joining Achillion in January 2009, Mr. Truitt was Vice President of Business Development and Product Strategy for Lev Pharmaceuticals, Inc., a biotechnology company, from October 2007 to December 2008. From July 2006 through September 2007, he served as Lev’s Vice President of Sales and Marketing and led the build out of the commercial team and infrastructure in preparation for product launch. From February 2002 to July 2006, Mr. Truitt was Vice President of Sales and Operations at Johnson & Johnson, a pharmaceutical company, where he directed commercial operations at the company’s OraPharma subsidiary. From 2000 to 2002, Mr. Truitt was Vice President of Sales and Operations of OraPharma, Inc., a pharmaceutical company, prior to its acquisition by Johnson & Johnson. Mr. Truitt holds an M.B.A. from St. Joseph’s University, Philadelphia and a B.S. in Marketing from LaSalle University, Philadelphia.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
384,576 -- 502,041 886,617

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Scheer

--

Milind Deshpande

4,853,430

Mary Kay Fenton

989,616

Gautam Shah

883,243

David Apelian

2,175,130

Joseph Truitt

886,617
As Of 30 Dec 2013
Search Stocks